Log in or Sign up for Free to view tailored content for your specialty!
Mood Disorders News
Mood stabilizers not tied to higher risk for adverse pregnancy outcomes
Although women who used mood stabilizers were at increased risk for placenta-mediated pregnancy complications, study data showed that this increased risk was most likely not because of the treatment.
Adding citalopram to stimulants may benefit youth with severe irritability
Youth unresponsive to stimulant medication alone saw greater improvement in severe irritability symptoms when they received add-on citalopram than those who received add-on placebo, according to double-blind randomized placebo-controlled trial results.
Log in or Sign up for Free to view tailored content for your specialty!
Genetic liability for MDD boosts risk for suicide attempt across psychiatric disorders
Genetic liability for major depressive disorder increased the risk for suicide attempt in patients with major depressive disorder, bipolar disorder and schizophrenia, according to results from a large genome-wide association study published in American Journal of Psychiatry.
Add-on fish oil for depressed patients with heart disease requires further study
Augmenting sertraline with an omega-3 fatty acid for 10 weeks did not result in greater improvement in depressive symptoms compared with sertraline and corn oil placebo in patients with major depressive disorder and coronary heart disease, according to a study published in Journal of Clinical Psychiatry.
Many people with mental health disorders do not receive treatment
Most U.S. adults with mental health disorders have not received treatment for their conditions in the last year, and treatment rates were especially low for substance use disorders, according to 2012 to 2013 data from the National Epidemiologic Survey on Alcohol and Related Conditions-III.
Nearly 1 in 10 patients treated for MDD receive benzodiazepine monotherapy
Researchers found that nearly one in 10 patients receiving treatment for depression were prescribed benzodiazepine monotherapy.
Ketamine’s mechanism of action still unclear, requires further investigation
SAN FRANCISCO — A panel of experts here agreed that while ketamine represents an effective therapy for patients with treatment-resistant depression and may have utility in other psychiatric conditions like OCD, there are still unanswered questions that require further study.
FDA approves expanded use of Vraylar for bipolar depression
The FDA has approved a supplemental New Drug Application, or sNDA, for Vraylar for the expanded use to treat depressive episodes associated with bipolar I disorder in adults, according to a press release.
Benzodiazepine use early in pregnancy may boost risk of spontaneous abortion
Exposure to any benzodiazepine agent in early pregnancy was associated with a higher risk for spontaneous abortion, according to data published in JAMA Psychiatry.
Top stories to read during Mental Health Awareness Month
Although millions of individuals in the United States are affected by mental health conditions, stigma can prevent people receiving the care and attention they need.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read